AFP and chronic hepatitis: Thus, in order to significantly improve the diagnostic accuracy for HCC, additional biomarkers are needed to complement AFP, especially due to the fact that many patients with benign liver diseases, such as chronic hepatitis, liver cirrhosis, and gastrointestinal cancer, also have elevated serum AFP.